CPhI Japan celebrates return, as cell & gene therapies and digital innovation highlighted – PharmiWeb.com

CPhI Japan, the first large pharma event to trade in 2021, played host to 7214 attendees at the exhibition and a further 7204 virtual users from across the globe. The event, a key marker for the strength of the regional industry, has rebounded quickly with some 216 exhibitors searching for pharma partners. In fact, such has been the demand, CPhI Japan Connect the events digital platform for international audiences will remain open until the end of May.

Hosted at the Big Sight Exhibition Centre in Tokyo, the countrys cell and gene therapy sector, the expanding domestic R&D pipeline and renewed digital innovation were highlighted by experts as key growth areas in 2021.

The feedback on the ground was that the chance to meet again with industry professionals has really stimulated some extremely active discussions. From API producers and packaging to advanced therapies, the event played host to a really active couple of days that has reinvigorated growth and partnerships in Japan over the next year, commented Silvia Forroova, Brand Director Pharma at CPhI Japan.

Attendees highlighted the return of the event and its success as a key moment for renewed pharma growth in Japan. In fact, Japan (7.15) ranked second only to the United States in the most recent Annual CPhI Pharma Index, scoring extremely highly across innovation (7.34), API quality (7.78), finished dose manufacturing (8.13) as well as biologics manufacturing (7.20).

In one session, the strength of the countrys advanced therapy market was discussed in Trends in Cell and Gene Therapy presented by Ly Nguyen-Jatkoe of Informa Pharma Intelligence with rapid growth expected over the next 2-3 years.

In total, Japans largest pharma trade event saw an extremely strong industry turnout with 216 exhibitors from across the full spectrum of pharmaceutical supply chain.

Laura Murina, Brand Manager at CPhI Japan added, the great strength of CPhI events is that we bring everyone together and adopting a hybrid approach to CPhI Japan has been a great success empowering partnerships, international as well as domestic, and keeping vital connections and trends following across the industry.

Beyond the exhibition, the CPhI Japan Conference featured keynote insights, including a detailed appraisal of the dynamic R&D pipeline from Ian Haydock, Editor-In-Chief, Asia Pacific Informa Intelligence. Additionally, Timothy Pang and Caroline Zhang of Informa Pharma Intelligence presented analysis of Chinas growing pharma market; with Angela Irony of Maccabi Healthcare, Omer Dror of Lynx MD and Amir Trabelsi of GENOOX reviewing the latest digital health trends.

Finally, the Japan Pharmaceutical Traders Association delivered the CPhI Japan 2021 Symposium, discussing the supply of APIs in Japan and how to manage change especially relevant in a post Covid period as well as an overview of the Japanese regulatory system and recent proposals for improvement.

Event organisers are already looking ahead to CPhI Japan 2022, which will take place at the Big Sight Exhibition in Tokyo (20-22 April), with numbers expected to near double to 15,000 attendees and 400 exhibitors. The event will be co-located alongside ICSE (contact services), P-MEC (pharmaceutical machinery & lab equipment), bioLIVE (biopharmaceuticals), InnoPack (packaging & drug delivery systems), NEX (natural extract), and FDF (finished dose drugs).

-ENDS-

Notes to editors

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, South East Asia, North America, and the Middle East and Africa. Co-locating with ICSE for contract services; P-MEC for machinery, equipment & technology; InnoPack for pharmaceutical packaging; bioLIVE for biopharma; Finished Dosage Formulation for every aspect of the finished dosage supply chain; and NEX for natural extract products, applications and solutions. CPhI provides an online buyer and supplier directory at CPhI-Online.com.

For more information visithttps://www.cphi.com

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the worlds leading exhibitions organizer, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.

For more information, please visit http://www.informamarkets.com.

The Informa Markets annual schedule of Pharmaceutical events include: CPhI Japan (14-16 April, 2021 at the Big Sight Exhibition Centre Tokyo, Japan); CPhI Discover (17 - 28 May 2021,Digital); CPhI South East Asia (4-6 August, 2021 at Challenger 2, IMPACT, Muang Thong Thani, Thailand); CPhI North America (10 August - 12 August, 2021 at Pennsylvania Convention Centre Philadelphia, USA); CPhI Korea (11-13 August 2021), COEX Seoul, Korea); CPhI, ICSE, P-MEC, FDF, InnoPack Worldwide, BioProduction (09 November 11 November 2021 at Fiera Milano, Milan); CPhI Middle East & Africa (26-28 September, 2021 at theRiyadh International Convention & Exhibition Center, Riyadh, Saudi Arabia); Pharmapack Europe 2021 (13-14 October, 2021 at the Paris Expo, Porte de Versailles Paris, France); CPhI & P-MEC India (24-26 November 2021 at the India Expo Mart, Greater Noida, Delhi NCR Delhi, India); CPhI & P-MEC China (Dec. 16 to 18, 2021 at SNIEC Shanghai, China)

For media enquiries, please contact:

Alex Heeley or Abdul Khalifeh

De Facto Communications

T: +44 (0) 203 735 8168

E:a.heeley@defacto.co.uk/a.khalifeh@defacto.co.uk

See the rest here:
CPhI Japan celebrates return, as cell & gene therapies and digital innovation highlighted - PharmiWeb.com